Childhood Polyarteritis Nodosa Follow-up

1. Bloch DA, Michel BA, Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990 Aug. 33(8):1068-73. [QxMD MEDLINE Link].

2. Mossberg M, Segelmark M, Kahn R, Englund M, Mohammad AJ. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden. Scand J Rheumatol. 2018 Feb 7. 1-8. [QxMD MEDLINE Link].

3. Guirola R, Hunter JV, Perez M, Muscal E. Childhood polyarteritis nodosa presenting with central nervous system manifestations and the posterior reversible encephalopathy syndrome. J Child Neurol. 2014 Jan. 29 (1):103-7. [QxMD MEDLINE Link].

4. Beckum KM, Kim DJ, Kelly DR, Weiser P, Lara DA, Theos A. Polyarteritis nodosa in childhood: recognition of early dermatologic signs may prevent morbidity. Pediatr Dermatol. 2014 Jan-Feb. 31 (1):e6-9. [QxMD MEDLINE Link].

5. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet. 1970 Dec 5. 2(7684):1149-53. [QxMD MEDLINE Link].

6. Duffy J; Lidsky MD; Sharp JT; Davis JS; Person DA; Hollinger FB; Min KW. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore). 1976 Jan. 55(1):19-37. [QxMD MEDLINE Link].

7. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J. 2006 Mar. 25(3):245-9. [QxMD MEDLINE Link].

8. Googe JM Jr, Brady SE, Argyle JC, Apple DJ, Gooch WM 3rd. Choroiditis in infantile periarteritis nodosa. Arch Ophthalmol. 1985 Jan. 103(1):81-3. [QxMD MEDLINE Link].

9. Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr. 1978 Aug 17. 129(1):17-27. [QxMD MEDLINE Link].

10. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997 Nov 20. 337(21):1512-23. [QxMD MEDLINE Link].

11. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb. 37(2):187-92. [QxMD MEDLINE Link].

12. Kallenberg CGM. Taxonomy of the vasculitis syndromes. Van de Putte LBA, Furst DE, Williams HJ, van Riel PLCM, eds. Therapy of Systemic Rheumatic Disorders. New York: Marcel Dekker, Inc; 1998. 563-570.

13. Lie JT. Biopsy Diagnosis in Rheumatic Diseases. New York: IGAKU-SHOIN; 1997. 61-106: 175-179.

14. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum. 1990 Aug. 33(8):1074-87. [QxMD MEDLINE Link].

15. Lightfoot RW Jr, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990 Aug. 33(8):1088-93. [QxMD MEDLINE Link].

16. Long SS. Fifty years ago in the Journal of Pediatrics. J Pediatr. 1999. 135:171.

17. Matteson EL. A history of early investigation in polyarteritis nodosa. Arthritis Care Res. 1999 Aug. 12(4):294-302. [QxMD MEDLINE Link].

18. Person DA. Vasculitis. Case Based Pediatrics for Medical Students and Residents. August 2002. Chapter XVI.3:

19. Person DA, He X, Brewer EJ Jr. Vasculitis in children with juvenile rheumatoid arthritis. Hick RV. Vasculopathies of Childhood. 1988. 156-160.

20. Shulman ST. The first reported case of Kawasaki disease?. J Pediatr. 1999 Oct. 135(4):532. [QxMD MEDLINE Link].

21. Tanaka N. Kawasaki disease (acute febrile infantile muco-cutaneous lymph node syndrome) in Japan; relationship with infantile periarteritis nodosa. Pathol Microbiol (Basel). 1975. 43(2-O):204-18. [QxMD MEDLINE Link].

22. Wada Y, Kamei A, Fujii Y, Ishikawa K, Chida S. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. J Pediatr. 2006 Mar. 148(3):399-400. [QxMD MEDLINE Link].

23. Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014 Mar 6. 370 (10):921-31. [QxMD MEDLINE Link]. [Full Text].

24. Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J. 2014. 12:44. [QxMD MEDLINE Link]. [Full Text].

25. Garg N, Kasapcopur O, Foster J 2nd, Barut K, Tekin A, Kızılkılıç O, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr. 2014 Jun. 173 (6):827-30. [QxMD MEDLINE Link].

Donald A Person, MD, FAAP, FACR Medical Director (Emeritus), Pacific Island Healthcare Project; Expert Consultant in Pediatrics, Pediatric Rheumatology, Telemedicine, and Scientific Review, Tripler Army Medical Center; Professor of Pediatrics, F Edward Herbert School of Medicine, Uniformed Services University of the Health Sciences; Clinical Professor of Pediatrics and Public Health (Retired), University of Hawaii, John A Burns School of Medicine

Donald A Person, MD, FAAP, FACR is a member of the following medical societies: American Academy of Pediatrics, American College of Rheumatology, American Medical Association, American Pediatric Society, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Association of Military Surgeons of the US, Clinical Immunology Society, Federation of American Societies for Experimental Biology, Pediatric Infectious Diseases Society, Society for Experimental Biology and Medicine, Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Lawrence K Jung, MD Chief, Division of Pediatric Rheumatology, Children's National Medical Center

Lawrence K Jung, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Rheumatology, Clinical Immunology Society, New York Academy of Sciences

Disclosure: Nothing to disclose.

Barry L Myones, MD Co-Chair, Task Force on Pediatric Antiphospholipid Syndrome

Barry L Myones, MD is a member of the following medical societies: American Association of Immunologists, American Heart Association, American Society for Microbiology, Clinical Immunology Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article